The purpose of the study is to assess the benefits of a therapeutic strategy that associates
an early administration of human fibrinogen concentrate in the management of PPH on the
reduction of bleeding after the initiation of prostaglandins intravenous infusion, following
vaginal delivery.
Phase:
Phase 4
Details
Lead Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies